Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Totals |
||
Shortage reports |
127 |
|
| Actual shortage: | 14 (11%) | |
| Anticipated shortage: | 2 (2%) | |
| Avoided shortage: | 5 (4%) | |
| Resolved: | 106 (83%) | |
Discontinuation Reports |
3 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (67%) | |
| Reversed: | 1 (33%) | |
Late reports |
17 (13%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PHENOBARB | 60MG | TABLET | Resolved | 2018-05-17 | 2018-11-02 | 49674 |
| PHENOBARB | 60MG | TABLET | Resolved | 2018-12-28 | 2019-04-17 | 70690 |
| PHENOBARB | 60MG | TABLET | Resolved | 2022-12-12 | 2023-03-17 | 177960 |
| PHENOBARB | 60MG | TABLET | Resolved | 2023-06-19 | 2023-07-31 | 195462 |
| PHENOBARB | 60MG | TABLET | Resolved | 2024-07-15 | 2024-07-27 | 232933 |
| SOLYSTAT | 94.3MG | POWDER | Resolved | 2018-12-07 | 2018-12-20 | 68901 |
| SOLYSTAT | 94.3MG | POWDER | Avoided shortage | 2018-12-28 | 2019-04-12 | 70683 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBAVYR | 200MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182060 |
| IBAVYR | 400MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182029 |
| OCPHYL | 500MCG | SOLUTION | Reversed | 2017-04-10 | 2017-04-10 | 6237 |
Showing 1 to 3 of 3